High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study
- 1 December 1997
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 33 (14) , 2368-2375
- https://doi.org/10.1016/s0959-8049(97)10019-3
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.Journal of Clinical Oncology, 1996
- Results of a stage-based protocol for the treatment of retinoblastoma.Journal of Clinical Oncology, 1996
- Histopathologic risk factors in retinoblastoma: A retrospective study of 172 patients treated in a single institutionCancer, 1996
- Etoposide and carboplatin in extraocular retinoblastoma: a study by the Société Française d'Oncologie Pédiatrique.Journal of Clinical Oncology, 1995
- The role of chemotherapy in orbital involvement of retinoblastoma. The experience of a single institution with 33 patientsCancer, 1994
- Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factorsCancer, 1994
- Chemotherapy for Extraocular RetinoblastomaPediatric Hematology and Oncology, 1994
- High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better toleratedCancer, 1992
- Chemotherapy in RetinoblastomaJournal of Pediatric Hematology/Oncology, 1991
- High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age.Journal of Clinical Oncology, 1987